Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
PP&E Net
Burning Rock Biotech Ltd
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
PP&E Net
¥144.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
PP&E Net
¥9.3B
|
CAGR 3-Years
54%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
PP&E Net
¥4.9B
|
CAGR 3-Years
30%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
PP&E Net
¥2.9B
|
CAGR 3-Years
46%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
PP&E Net
¥5.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
26%
|
CAGR 10-Years
25%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
PP&E Net
¥279.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's PP&E Net?
PP&E Net
144.2m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's PP&E Net amounts to 144.2m CNY.
What is Burning Rock Biotech Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
16%
Over the last year, the PP&E Net growth was -52%. The average annual PP&E Net growth rates for Burning Rock Biotech Ltd have been 9% over the past three years , 16% over the past five years .